• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

III型CRISPR-Cas系统的环状寡腺苷酸信号通路

The Cyclic Oligoadenylate Signaling Pathway of Type III CRISPR-Cas Systems.

作者信息

Huang Fengtao, Zhu Bin

机构信息

Key Laboratory of Molecular Biophysics, the Ministry of Education, College of Life Science and Technology and Shenzhen College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Microbiol. 2021 Jan 20;11:602789. doi: 10.3389/fmicb.2020.602789. eCollection 2020.

DOI:10.3389/fmicb.2020.602789
PMID:33552016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7854544/
Abstract

Type III CRISPR-Cas systems, which are widespread in both bacteria and archaea, provide immunity against DNA viruses and plasmids in a transcription-dependent manner. Since an unprecedented cyclic oligoadenylate (cOA) signaling pathway was discovered in type III systems in 2017, the cOA signaling has been extensively studied in recent 3 years, which has expanded our understanding of type III systems immune defense and also its counteraction by viruses. In this review, we summarized recent advances in cOA synthesis, cOA-activated effector protein, cOA signaling-mediated immunoprotection, and cOA signaling inhibition, and highlighted the crosstalk between cOA signaling and other cyclic oligonucleotide-mediated immunity discovered very recently.

摘要

III型CRISPR-Cas系统广泛存在于细菌和古生菌中,以转录依赖的方式提供针对DNA病毒和质粒的免疫。自2017年在III型系统中发现前所未有的环状寡腺苷酸(cOA)信号通路以来,近3年对cOA信号进行了广泛研究,这扩展了我们对III型系统免疫防御及其病毒对抗作用的理解。在本综述中,我们总结了cOA合成、cOA激活效应蛋白、cOA信号介导的免疫保护和cOA信号抑制方面的最新进展,并强调了cOA信号与最近发现的其他环状寡核苷酸介导的免疫之间的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/424b/7854544/aecb2490d845/fmicb-11-602789-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/424b/7854544/aecb2490d845/fmicb-11-602789-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/424b/7854544/aecb2490d845/fmicb-11-602789-g001.jpg

相似文献

1
The Cyclic Oligoadenylate Signaling Pathway of Type III CRISPR-Cas Systems.III型CRISPR-Cas系统的环状寡腺苷酸信号通路
Front Microbiol. 2021 Jan 20;11:602789. doi: 10.3389/fmicb.2020.602789. eCollection 2020.
2
The diverse arsenal of type III CRISPR-Cas-associated CARF and SAVED effectors.III 型 CRISPR-Cas 相关的 CARF 和 SAVED 效应因子的多样化武器库。
Biochem Soc Trans. 2022 Oct 31;50(5):1353-1364. doi: 10.1042/BST20220289.
3
Type III CRISPR-Cas: beyond the Cas10 effector complex.III 型 CRISPR-Cas:超越 Cas10 效应物复合物。
Trends Biochem Sci. 2024 Jan;49(1):28-37. doi: 10.1016/j.tibs.2023.10.006. Epub 2023 Nov 8.
4
Investigation of the cyclic oligoadenylate signaling pathway of type III CRISPR systems.III型CRISPR系统环状寡腺苷酸信号通路的研究
Methods Enzymol. 2019;616:191-218. doi: 10.1016/bs.mie.2018.10.020. Epub 2019 Jan 12.
5
Csx3 is a cyclic oligonucleotide phosphodiesterase associated with type III CRISPR-Cas that degrades the second messenger cA.Csx3 是一种与 III 型 CRISPR-Cas 相关的环核苷酸磷酸二酯酶,可降解第二信使 cA。
J Biol Chem. 2020 Oct 30;295(44):14963-14972. doi: 10.1074/jbc.RA120.014099. Epub 2020 Aug 21.
6
Regulation of cyclic oligoadenylate synthesis by the Cas10-Csm complex.Cas10-Csm 复合物对环寡腺苷酸合成的调控。
RNA. 2019 Aug;25(8):948-962. doi: 10.1261/rna.070417.119. Epub 2019 May 10.
7
Enzymatic properties of CARF-domain proteins in sp. PCC 6803.集胞藻PCC 6803中CARF结构域蛋白的酶学特性
Front Microbiol. 2022 Nov 7;13:1046388. doi: 10.3389/fmicb.2022.1046388. eCollection 2022.
8
Evolutionary and functional classification of the CARF domain superfamily, key sensors in prokaryotic antivirus defense.CARF 结构域超家族的进化和功能分类,原核抗病毒防御的关键传感器。
Nucleic Acids Res. 2020 Sep 18;48(16):8828-8847. doi: 10.1093/nar/gkaa635.
9
Structural basis of cyclic oligoadenylate binding to the transcription factor Csa3 outlines cross talk between type III and type I CRISPR systems.环状寡聚腺苷酸与转录因子 Csa3 结合的结构基础概述了 III 型和 I 型 CRISPR 系统之间的串扰。
J Biol Chem. 2022 Feb;298(2):101591. doi: 10.1016/j.jbc.2022.101591. Epub 2022 Jan 14.
10
Cyclic oligoadenylate signalling and regulation by ring nucleases during type III CRISPR defence.III型CRISPR防御过程中环状寡腺苷酸信号传导及核糖核酸酶的调控
RNA. 2021 May 13;27(8):855-67. doi: 10.1261/rna.078739.121.

引用本文的文献

1
Cyanobacterial Argonautes and Cas4 family nucleases cooperate to interfere with invading DNA.蓝藻精氨酸酶和Cas4家族核酸酶协同作用以干扰入侵DNA。
Mol Cell. 2025 May 15;85(10):1920-1937.e10. doi: 10.1016/j.molcel.2025.03.025. Epub 2025 Apr 26.
2
Editing microbes to mitigate enteric methane emissions in livestock.编辑微生物以减少家畜肠道甲烷排放。
World J Microbiol Biotechnol. 2024 Aug 13;40(10):300. doi: 10.1007/s11274-024-04103-x.
3
Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in .亚抑菌浓度的抗生素增加了CRISPR-Cas在……中的适应性代价。

本文引用的文献

1
A Membrane-Associated DHH-DHHA1 Nuclease Degrades Type III CRISPR Second Messenger.一种膜相关的 DHH-DHHA1 核酸酶降解 III 型 CRISPR 第二信使。
Cell Rep. 2020 Sep 15;32(11):108133. doi: 10.1016/j.celrep.2020.108133.
2
Csx3 is a cyclic oligonucleotide phosphodiesterase associated with type III CRISPR-Cas that degrades the second messenger cA.Csx3 是一种与 III 型 CRISPR-Cas 相关的环核苷酸磷酸二酯酶,可降解第二信使 cA。
J Biol Chem. 2020 Oct 30;295(44):14963-14972. doi: 10.1074/jbc.RA120.014099. Epub 2020 Aug 21.
3
Type III-A CRISPR-associated protein Csm6 degrades cyclic hexa-adenylate activator using both CARF and HEPN domains.
Front Microbiol. 2024 Jul 1;15:1381749. doi: 10.3389/fmicb.2024.1381749. eCollection 2024.
4
Nucleotides as Bacterial Second Messengers.核苷酸作为细菌的第二信使。
Molecules. 2023 Dec 7;28(24):7996. doi: 10.3390/molecules28247996.
5
Allosteric crosstalk in modular proteins: Function fine-tuning and drug design.模块化蛋白质中的变构串扰:功能微调与药物设计。
Comput Struct Biotechnol J. 2023 Oct 10;21:5003-5015. doi: 10.1016/j.csbj.2023.10.013. eCollection 2023.
6
Evolution of CRISPR/Cas Systems for Precise Genome Editing.CRISPR/Cas 系统的进化用于精确基因组编辑。
Int J Mol Sci. 2023 Sep 18;24(18):14233. doi: 10.3390/ijms241814233.
7
Precise transcript targeting by CRISPR-Csm complexes.CRISPR-Csm 复合物的精确转录靶向。
Nat Biotechnol. 2023 Sep;41(9):1256-1264. doi: 10.1038/s41587-022-01649-9. Epub 2023 Jan 23.
8
Development of clustered regularly interspaced short palindromic repeats/CRISPR-associated technology for potential clinical applications.用于潜在临床应用的成簇规律间隔短回文重复序列/CRISPR相关技术的发展
World J Clin Cases. 2022 Jun 26;10(18):5934-5945. doi: 10.12998/wjcc.v10.i18.5934.
III-A 型 CRISPR 相关蛋白 Csm6 使用 CARF 和 HEPN 结构域降解环状六腺苷酸激活剂。
Nucleic Acids Res. 2020 Sep 18;48(16):9204-9217. doi: 10.1093/nar/gkaa634.
4
Evolutionary and functional classification of the CARF domain superfamily, key sensors in prokaryotic antivirus defense.CARF 结构域超家族的进化和功能分类,原核抗病毒防御的关键传感器。
Nucleic Acids Res. 2020 Sep 18;48(16):8828-8847. doi: 10.1093/nar/gkaa635.
5
Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas.Cmr-β 复合物结构揭示了 III-B 型 CRISPR-Cas 免疫机制的调节。
Mol Cell. 2020 Sep 3;79(5):741-757.e7. doi: 10.1016/j.molcel.2020.07.008. Epub 2020 Jul 29.
6
Structural basis of CRISPR-Cas Type III prokaryotic defence systems.CRISPR-Cas Ⅲ 型原核防御系统的结构基础。
Curr Opin Struct Biol. 2020 Dec;65:119-129. doi: 10.1016/j.sbi.2020.06.010. Epub 2020 Jul 23.
7
Tetramerisation of the CRISPR ring nuclease Crn3/Csx3 facilitates cyclic oligoadenylate cleavage.CRISPR环状核酸酶Crn3/Csx3的四聚化促进环状寡腺苷酸的切割。
Elife. 2020 Jun 29;9:e57627. doi: 10.7554/eLife.57627.
8
CBASS Immunity Uses CARF-Related Effectors to Sense 3'-5'- and 2'-5'-Linked Cyclic Oligonucleotide Signals and Protect Bacteria from Phage Infection.CBASS 免疫利用 CARF 相关效应子来感知 3'-5'-和 2'-5'-连接的环状寡核苷酸信号,并保护细菌免受噬菌体感染。
Cell. 2020 Jul 9;182(1):38-49.e17. doi: 10.1016/j.cell.2020.05.019. Epub 2020 Jun 15.
9
Fuse to defuse: a self-limiting ribonuclease-ring nuclease fusion for type III CRISPR defence.熔解来解除:III 型 CRISPR 防御的一种自我限制的核糖核酸酶-环核酶融合。
Nucleic Acids Res. 2020 Jun 19;48(11):6149-6156. doi: 10.1093/nar/gkaa298.
10
The dynamic interplay of host and viral enzymes in type III CRISPR-mediated cyclic nucleotide signalling.III 型 CRISPR 介导的环核苷酸信号中宿主和病毒酶的动态相互作用。
Elife. 2020 Apr 27;9:e55852. doi: 10.7554/eLife.55852.